{
    "clinical_study": {
        "@rank": "142975", 
        "arm_group": [
            {
                "arm_group_label": "Severe sepsis", 
                "description": "Patients with severe sepsis"
            }, 
            {
                "arm_group_label": "Infectious kidney stone", 
                "description": "Patients with sepsis after PCNL for infectious kidney stone"
            }, 
            {
                "arm_group_label": "Tumor", 
                "description": "Patients with pancreatic cancer"
            }, 
            {
                "arm_group_label": "Volunteer"
            }
        ], 
        "biospec_descr": {
            "textblock": "Peripheral blood sample was collected for detection of neutrophil PD-L1, monocyte HLA-DR and\n      lymphocyte PD-1."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Immunosuppression is the leading cause of death in septic patients. Neutrophils are\n      classical components of innate immunology, but recent studies showed that neutrophils might\n      display antigen presenting function and inhibit lymphocyte proliferation by expressing\n      programmed cell death 1 ligand 1 (PD-L1). Whether neutrophils express PD-L1 and its role in\n      immunosuppression during sepsis remain unclear."
        }, 
        "brief_title": "Expression and the Clinical Significance of Neutrophil PD-L1 During Sepsis", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Sepsis", 
            "Immunosuppression"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with severe sepsis\n\n          -  patients with sepsis after PCNL for infectious kidney stone\n\n          -  patients with pancreatic cancer\n\n          -  healthy volunteers\n\n        Exclusion Criteria:\n\n          -  patients with immunodeficient diseases\n\n          -  patients who accept glucocorticoid or immunosuppressant\n\n          -  patients with an age older than 18 years\n\n          -  patients providing the informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients admitted in ICU at Changhai Hospital"
            }
        }, 
        "enrollment": {
            "#text": "71", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976884", 
            "org_study_id": "NeutrophilPD-L1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sepsis", 
            "immunosuppression", 
            "PD-L1"
        ], 
        "lastchanged_date": "October 30, 2013", 
        "number_of_groups": "4", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: National Natural Science Foundation", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "PD-L1 level on neutrophils was compared between different populations.", 
            "measure": "PD-L1 level on neutrophils", 
            "safety_issue": "No", 
            "time_frame": "within 24h after recruitment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976884"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Changhai Hospital", 
            "investigator_full_name": "Jia-feng Wang", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "28-day mortality", 
            "safety_issue": "No", 
            "time_frame": "28 days after diagnosis of sepsis"
        }, 
        "source": "Changhai Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Changhai Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}